New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Agile Therapeutics, Inc.
AGRX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

10M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

10M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

1.51USD
Shape0.05 ( 3.42%)
favorite-chart

Relative Strenght

2
favorite-chart

Volume Buzz

-17%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

43%

Quote Panel

Shape
Updated October 18, 2024
1W % 1M % 3M 5.59 % 1Y -19.68 %

Key Metrics

Shape
  • Market Cap

    10.43M


  • Shares Outstanding

    6.90M


  • Share in Float

    5.14M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    1.51


  • Average Volume

    143293


  • Beta

    1.582


  • Range

    0.2-2.63


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.agiletherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.48x

P/S Ratio

-0.47x

P/B Ratio

-0.0

Debt/Equity

-73.5%

Net Margin

$-1.7

EPS

How AGRX compares to sector?

P/E Ratio

Relative Strength

Shape

AGRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$51M

Shape813%

2025-Revenue

$1.10

Shape164%

2025-EPS

$30M

Shape-1010%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Maxim Group

upgrade

Previous: Not converted

2023-09-22

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-11.50
vs -360.00

Q4.22

arrow
arrow

N/A

-9.00
vs -400.00

Q1.23

arrow
arrow

N/A

-7.76
vs -189.00

Q2.23

arrow
arrow

N/A

-3.10
vs -135.50

Q3.23

arrow
arrow

N/A

-1.47
vs -11.50

Q4.23

arrow
arrow

N/A

-1.46
vs -9.00

Q1.24

arrow
arrow

N/A

-0.63
vs -7.76

Q2.24

arrow
arrow

N/A

-0.68
vs -3.10

Q3.24

arrow
arrow

N/A

-0.04
vs -1.47

Q4.24

arrow
arrow

+107%

0.1
vs -1.46

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+133%

3M  vs 1.3M

Q4.22

arrow
arrow

+164%

4M  vs 1.5M

Q1.23

arrow
arrow

+117%

3.8M  vs 1.8M

Q2.23

arrow
arrow

+159%

5.5M  vs 2.1M

Q3.23

arrow
arrow

+122%

6.7M  vs 3M

Q4.23

arrow
arrow

-10%

3.6M  vs 4M

Q1.24

arrow
arrow

+50%

5.7M  vs 3.8M

Q2.24

arrow
arrow

+1%

5.6M  vs 5.5M

Q3.24

arrow
arrow

+41%

9.4M  vs 6.7M

Q4.24

arrow
arrow

+211%

11.3M  vs 3.6M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-352%

-3.52
vs -3.57

Q4.22

arrow
arrow

+239%

2.39
vs -3.52

Q1.23

arrow
arrow

+38%

0.38
vs 2.39

Q2.23

arrow
arrow

+31%

0.31
vs 0.38

Q3.23

arrow
arrow

+6%

0.06
vs 0.31

Q4.23

arrow
arrow

+27%

0.27
vs 0.06

Q1.24

arrow
arrow

-12%

-0.12
vs 0.27

Q2.24

arrow
arrow

+54%

0.54
vs -0.12

Institutionnal OwnershipShape

status-upQoQ

Q3.20

arrow
arrow

86

86
vs 85

1%

Q4.20

arrow
arrow

85

85
vs 86

-1%

Q1.21

arrow
arrow

80

80
vs 85

-6%

Q2.21

arrow
arrow

72

72
vs 80

-10%

Q3.21

arrow
arrow

54

54
vs 72

-25%

Q4.21

arrow
arrow

47

47
vs 54

-13%

Q1.22

arrow
arrow

35

35
vs 47

-26%

Q4.23

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News